Bavarian Biotech Report 2011/2012 (7MB) - Bio M

ContentThe Bavarian Biotechnology Cluster 07Prof. Dr. Horst Domdey – Speaker of the “Bavarian Biotechnology Cluster”The 2011 Biotech Year in Bavaria – And Beyond 08-14Facts and Figures 15-26Employment 17-18Jobs in Biotechnology CompaniesProducts and Pipeline 19-21Drug DevelopmentDeals, Cooperation, Mergers, Financing 22-26Deals and CooperationM&A-ActivityFinancingRevenuesSummaryIndustrial Biotechnology on the move 28-29Company Profiles 31-121in alphabetical orderAbout this survey:For the following report, a biotechnology company has been defined as a company, which develops and/ormanufactures products on the basis of state-of-the-art molecular biological methods. But as “conventional”pharmaceutical companies are increasingly also using such methods, it is often difficult to differentiatebetween biotech and pharma. Traditional phytopharmaceutical companies and manufacturers of homeopathicproducts are however not included in this compilation. We distinguished the parameters specific toeach sector and conducted separate surveys for biotech companies, pharmaceutical companies, (clinical)contract research organizations (CROs), contract manufacturing organizations (CMOs), suppliers andothers with activities in the biotechnology sector. In the case of the biotech companies, a distinction wasonce again made between small and medium-sized companies (SME) having their headquarters inBavaria, and branch offices and subsidiaries of national and international biotech companies (biotechnologycompanies, non-SMEs). The term “non-SME” therefore does not say anything about the actual size of thisbranch office.The data forming the basis of this report are based on the evaluation of a written survey carried out byBioM Biotech Cluster Development GmbH at the beginning of 2012 of approx. 320 Life Science companiesthroughout Bavaria. Based on the questionnaires returned and intensive follow-up telephone calls it waspossible to achieve a response rate of almost 86%. Possible deviations from previously published figuresare the result of additional data obtained in this survey that also may refer to previous years. The periodunder review for this report is the year 2011.Published in April 20125